tiprankstipranks
Global Health Limited (AU:GLH)
ASX:GLH
Australian Market
Want to see AU:GLH full AI Analyst Report?

Global Health Limited (GLH) AI Stock Analysis

1 Followers

Top Page

AU:GLH

Global Health Limited

(Sydney:GLH)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
AU$0.06
▼(-36.67% Downside)
Action:Reiterated
Date:03/24/26
The score is held down primarily by weak financial fundamentals—ongoing losses, negative operating/free cash flow, and especially negative equity—despite improving revenue and margins. Technicals add further pressure with a weak downtrend and negative momentum indicators. Valuation provides limited support because the company is still loss-making and has no stated dividend yield.
Positive Factors
Revenue Growth
Sustained top-line expansion over multiple years indicates underlying demand and market traction for the company's services. A growing revenue base improves operating leverage potential and provides a firmer platform to scale infrastructure, pricing power and incremental profit as margins continue to recover.
Negative Factors
Negative Shareholders' Equity
Sustained negative equity is a structural capital weakness that raises insolvency and refinancing risk. It constrains access to credit, limits strategic flexibility, and increases the likelihood of dilutive equity raises or onerous financing terms, impairing long-term stability unless capitalized or reversed.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained top-line expansion over multiple years indicates underlying demand and market traction for the company's services. A growing revenue base improves operating leverage potential and provides a firmer platform to scale infrastructure, pricing power and incremental profit as margins continue to recover.
Read all positive factors

Global Health Limited (GLH) vs. iShares MSCI Australia ETF (EWA)

Global Health Limited Business Overview & Revenue Model

Company Description
Headquartered in Melbourne, Australia, and established in 1985, Global Health Limited develops and supplies digital health solutions for the Australian healthcare sector. Their comprehensive suite of software addresses various needs, including spe...

Global Health Limited Financial Statement Overview

Summary
Operating performance is improving (revenue growth and a FY2025 gross margin rebound), and losses/cash burn have narrowed versus FY2023. However, the company remains loss-making with negative operating/free cash flow, and the most significant weakness is negative shareholders’ equity, which increases balance-sheet risk and limits financial flexibility.
Income Statement
24
Negative
Balance Sheet
18
Very Negative
Cash Flow
22
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue7.93M8.67M8.12M7.82M6.54M7.03M
Gross Profit564.77K2.10M-689.94K-2.18M-664.00K812.71K
EBITDA-1.23M-793.08K-1.77M-7.19M-1.69M57.05K
Net Income-809.08K-866.63K-1.31M-8.05M-2.05M-488.00K
Balance Sheet
Total Assets2.12M2.84M3.08M3.12M11.03M9.04M
Cash, Cash Equivalents and Short-Term Investments1.04M1.38M2.07M2.24M6.38M4.84M
Total Debt1.63M1.46M1.03M44.94K141.83K304.11K
Total Liabilities6.46M6.58M5.98M4.74M4.95M5.00M
Stockholders Equity-4.35M-3.73M-2.90M-1.62M6.09M4.04M
Cash Flow
Free Cash Flow-320.49K-706.63K-1.15M-4.36M-2.08M675.18K
Operating Cash Flow-309.73K-706.63K-1.13M-3.46M-1.18M1.37M
Investing Cash Flow-22.09K5.00K-17.48K-902.77K-778.93K-428.74K
Financing Cash Flow-356.80K-10.70K982.56K240.86K3.50M3.23M

Global Health Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.09
Price Trends
50DMA
0.06
Positive
100DMA
0.06
Negative
200DMA
0.08
Negative
Market Momentum
MACD
<0.01
Negative
RSI
64.49
Neutral
STOCH
70.53
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:GLH, the sentiment is Positive. The current price of 0.09 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.06, and above the 200-day MA of 0.08, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 64.49 is Neutral, neither overbought nor oversold. The STOCH value of 70.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:GLH.

Global Health Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
AU$9.91B36.545.75%2.25%8.65%3233.99%
56
Neutral
AU$1.84B48.26-162.99%2.30%14.95%151.90%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
47
Neutral
AU$8.56M-8.80404.65%67.74%78.79%
43
Neutral
AU$240.02M-17.26-4.47%-21.29%-167.20%
41
Neutral
AU$3.82M63.5915.41%-5.76%8.00%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:GLH
Global Health Limited
0.07
>-0.01
-12.16%
AU:EPN
Epsilon Healthcare Limited
0.02
>-0.01
-8.33%
AU:RHC
Ramsay Health Care
43.12
5.76
15.41%
AU:PGC
Paragon Care Limited
0.15
-0.24
-62.34%
AU:REG
Regis Healthcare Ltd.
6.09
-1.20
-16.40%
AU:FCG
Freedom Care Group Holdings Limited
0.04
0.00
0.00%

Global Health Limited Corporate Events

Global Health Redeems 100,000 Convertible Notes, Trimming Debt Exposure
Jul 2, 2026
Global Health Limited has notified the market that 100,000 of its GLHAM convertible notes have ceased following repayment or redemption without conversion as of June 30, 2026. The move reduces the company&#8217;s outstanding convertible debt, simp...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026